SCHEMBL28546201

SCHEMBL28546201

C=CC(=O)OCc1ccccc1S(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.43
CYP3A4 P08684 3/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 1/20 0.39
THRA P10827 1/20 0.37
MYC P01106 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
TSHR P16473 5/20 0.34
ALDH1A1 P00352 3/20 0.34
TP53 P04637 2/20 0.34
HIF1A Q16665 2/20 0.34
HSD17B10 Q99714 1/20 0.34
TGM2 P21980 3/20 0.33
F13A1 P00488 2/20 0.33
TGM1 P22735 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28326939 0.86 THRB (0.42) THRBCYP3A4MEN1CYP1A2CYP2D6
SCHEMBL28767937 0.85 THRB (0.51) THRBCYP3A4THRAMYCHCAR2
SCHEMBL6049594 0.84 CYP1A2 (0.42) CYP3A4MEN1CYP1A2CYP2D6CYP2C19
SCHEMBL29577996 0.83 THRB (0.53) THRBCYP3A4THRAHCAR2TSHR
SCHEMBL10451653 0.83 THRB (0.53) THRBCYP3A4THRAHCAR2TSHR
SCHEMBL29013762 0.80 MYC (0.41) CYP3A4MEN1CYP1A2CYP2D6CYP2C19
SCHEMBL6049596 0.79 MEN1 (0.40) CYP3A4MEN1CYP1A2CYP2D6CYP2C19
SCHEMBL29193217 0.79 ALDH1A1 (0.50) CYP3A4MEN1CYP1A2CYP2D6CYP2C19
SCHEMBL1455224 0.77 KMT2A (0.41) THRBCYP3A4MEN1CYP1A2CYP2D6
SCHEMBL7181027 0.77 THRB (0.47) THRBCYP3A4THRAHCAR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024203883-A1 OPHTHALMIC MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR 三菱ケミカル株式会社 2024-10-03 WO disclosed
US-20230348300-A1 WATER TREATMENT AGENT KAO CORPORATION (JP) 2023-11-02 US disclosed
EP-4249098-A1 WATER TREATMENT AGENT Kao Corporation (JP) 2023-09-27 EP disclosed
WO-2022107653-A1 WATER TREATMENT AGENT 花王株式会社 2022-05-27 WO disclosed
US-11261276-B2 Polymer, method for producing polymer and polymer flocculant MITSUBISHI CHEMICAL CORPORATION (JP) 2022-03-01 US disclosed
CN-109153749-B Polymer, method for producing polymer, and polymeric flocculant 三菱化学株式会社 2021-03-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11261276-B2 Polymer, method for producing polymer and polymer flocculant F12, MACF1, PFAS THRB 1840/4885CYP3A4 2017/4885MEN1 2624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.